Home > Boards > US Listed > Biotechs > Stemline Therapeutics (STML)

STML reports Q1 2019 results. First quarter since

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
biotech_researcher Member Profile
 
Followed By 67
Posts 12,010
Boards Moderated 0
Alias Born 07/25/08
160x600 placeholder
Annual Report (10-k) Edgar (US Regulatory) - 3/16/2020 5:05:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/13/2020 5:23:16 PM
Stemline Therapeutics Reports Fourth Quarter 2019 Financial Results GlobeNewswire Inc. - 3/13/2020 4:45:54 PM
Stemline Therapeutics to Host Conference Call on Fourth Quarter 2019 Financial Results on March 16, 2020 GlobeNewswire Inc. - 3/11/2020 4:05:10 PM
Stemline Therapeutics to Present at the Cowen 40th Annual Health Care Conference GlobeNewswire Inc. - 2/26/2020 7:30:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/18/2020 6:11:03 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/14/2020 8:54:38 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 4:13:44 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/12/2020 12:58:59 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/6/2020 9:17:22 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/4/2020 3:37:14 PM
Stemline Therapeutics Announces Preliminary 2019 Net Revenues for ELZONRIS® (tagraxofusp) and Highlights Commercial and Clin... GlobeNewswire Inc. - 1/13/2020 4:15:10 PM
Stemline Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 1/8/2020 4:15:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 5:20:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 5:19:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 5:19:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 5:18:38 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/23/2019 5:11:20 PM
Stemline Therapeutics Recaps ELZONRIS Clinical Data Presentations in Patients with Myelofibrosis (oral presentation) and Mult... GlobeNewswire Inc. - 12/10/2019 8:00:10 AM
Stemline Therapeutics Names Robert M. Francomano Chief Commercial Officer GlobeNewswire Inc. - 12/6/2019 6:30:10 PM
Stemline Therapeutics Highlights Three ELZONRIS Presentations, Including an Oral Presentation in Myelofibrosis, at Upcoming A... GlobeNewswire Inc. - 12/6/2019 7:00:10 AM
Stemline Therapeutics to Present at Piper Jaffray’s 31st Annual Healthcare Conference GlobeNewswire Inc. - 11/29/2019 1:05:10 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2019 4:35:07 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2019 5:30:28 PM
Stemline Therapeutics Reports Third Quarter 2019 Financial Results GlobeNewswire Inc. - 11/7/2019 4:57:35 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist